Frank P. DiNinno
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Frank P. DiNinno.
Bioorganic & Medicinal Chemistry Letters | 1999
Mark L. Greenlee; Joanne B. Laub; Gregory P. Rouen; Frank P. DiNinno; Milton L. Hammond; Joann Huber; Jon G. Sundelof; Gail G. Hammond
The synthesis and biological evaluation of a series of dicationic-substituted 2-fluorenonylcarbapenems is described. This class of compounds showed enhanced water solubility while maintaining potent activity against MRS. Introduction of a 1-beta-methyl substituent was found to improve pharmacokinetics.
Tetrahedron | 1983
William J. Leanza; Frank P. DiNinno; David A. Muthard; Robert R. Wilkening; Kenneth J. Wildonger; Ronald W. Ratcliffe; Burton G. Christensen
Abstract Allyl and p -nitrobenzyl (5R, 6S)-6-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-thioxopenam-3-carboxylates ( 19 ) were synthesized by base mediated cyclization of the corresponding 1-carboxylmethyl-4-phenoxy (thiocarbonyl)thio-2-azetidinones ( 16 ). The thioxopenams underwent alkylation and Michael reactions to produce 2-alkylthio- and 2-alkenylthio-penem derivatives 20 and 21 .
Tetrahedron Letters | 1990
Thomas A. Rano; Mark L. Greenlee; Frank P. DiNinno
Abstract A remarkably mild procedure for the synthesis of 2-aryl substituted carbapenems via a palladium catalyzed coupling reaction of a vinyl triflate with aryl stannanes is described. Employing Pd2(DBA)3.CHCl3 as the catalyst and tris(2,4,6-trimethoxyphenyl)phosphine as the ligand provides generous yields of the desired β-lactams. Reaction times are brief while reaction temperatures never exceed ambient.
Bioorganic & Medicinal Chemistry Letters | 1999
Robert R. Wilkening; Ronald W. Ratcliffe; Kenneth J. Wildonger; Lovji D. Cama; Kevin D. Dykstra; Frank P. DiNinno; Timothy A. Blizzard; Milton L. Hammond; James V. Heck; Karen Dorso; E.St. Rose; Joyce Kohler; Gail G. Hammond
A series of 1beta-methyl carbapenems substituted at the 2-position with lipophilic, acyclic and cyclic (sulfonamido)methyl groups was prepared and evaluated for activity against resistant gram-positive bacteria. From these studies, the 1,8-naphthosultamyl group emerged as a novel, PBP2a-binding, anti-MRSA pharmacophore worthy of further exploration.
Bioorganic & Medicinal Chemistry Letters | 2010
Qiang Tan; Aimie M. Ogawa; Ronald E. Painter; Young-Whan Park; Katherine Young; Frank P. DiNinno
4,7-Dichloro-1-benzothien-2-yl sulfonylaminomethyl boronic acid (DSABA, Compound I) was discovered as the first boronic acid-based class D beta-lactamase inhibitor. It exhibited an IC(50) of 5.6 microM against OXA-40. The compound also inhibited class A and C beta-lactamases with sub to low microM IC(50), and synergized with imipenem against Acinetobacter baumannii.
Tetrahedron Letters | 1999
Seongkon Kim; Jane Yang; Frank P. DiNinno
Abstract The boron trifluoride-etherate mediated cyclization of 2-arylthio-ketones 1a-h at ambient temperature gave 3-aryl-substituted benzothiophenes 2a-h in excellent yield. None of the rearranged 2-aryl-substituted benzothiophenes were observed.
Bioorganic & Medicinal Chemistry Letters | 1995
Laura C. Meurer; Ravindra N. Guthikonda; Joann Huber; Frank P. DiNinno
Abstract A series of 2-carbolinyl-carbapenems was prepared via the Stille stannane coupling reaction. This new class of antibiotics exhibited potent activity in vitro against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase negative staphylococci (MRCNS) as well as a broad spectrum of antibacterial activity. A high resistance to the mammalian dehydropeptidase, DHP-1, was also observed.
Bioorganic & Medicinal Chemistry Letters | 2011
Qiang Tan; Aimie M. Ogawa; Susan L. Raghoobar; Douglas Wisniewski; Lawrence F. Colwell; Young-Whan Park; Katherine Young; Jeffrey D. Hermes; Frank P. DiNinno; Milton L. Hammond
The preparation and characterization of a series of thiophenyl oxime phosphonate beta-lactamase inhibitors is described. A number of these analogs were potent and selective inhibitors of class C beta-lactamases from Pseudomonas aeruginosa and Enterobacter cloacae. Compounds 3b and 7 reduced the MIC of imipenem against an AmpC expressing strain of imipenem-resistant P. aeruginosa. A number of the title compounds retained micromolar potency against the class D OXA-40 beta-lactamase from Acinetobacter baumannii and at high concentrations compound 3b was shown to reduce the MIC of imipenem against a highly imipenem-resistant strain of A. baumanii expressing the OXA-40 beta-lactamase. In mice compound 3b exhibited phamacokinetics similar to imipenem.
Bioorganic & Medicinal Chemistry Letters | 1999
Mark L. Greenlee; Frank P. DiNinno; Jeffrey J. Herrmann; Cynthia Jaworsky; David A. Muthard; Thomas N. Salzmann
A regioisomeric set of 2-naphthylcarbapenems featuring cationic substituents was synthesized. Optimal placement of the cationic group was found to markedly improve activity against methicillin-resistant staphylococci while maintaining a good spectrum of gram-negative activity.
Bioorganic & Medicinal Chemistry Letters | 1995
Frank P. DiNinno; David A. Muthard; Thomas N. Salzmann; Joann Huber; Jean S. Kahan; Helmut Kropp
Abstract The discovery and synthesis of the arylcarbapenem 2b possessing potent activity against highly resistant strains of methicillin resistant staphylococci are dislosed.